MCRA, an IQVIA business
MCRA, an IQVIA business
  • 19
  • 8 764
Category III CPT Codes: Challenges and Opportunities - MCRA Webinar
Category III CPT Codes: Challenges and Opportunities Webinar
Category III CPT codes have a reputation for being relatively easy to obtain, but often difficult to get reimbursed. Category III codes are often an underappreciated opportunity for establishing premium payment.
Join MCRA’s Reimbursement experts John McDermott, Chaya Chavez, and Dr. Joel Brill for a deep dive into practical considerations for getting Category III codes, establishing appropriate payment, obtaining coverage, and converting to Category I codes. We will also provide a discussion of best practices for getting Category III CPT codes successfully paid.
The webinar took place on Tuesday, September 17th from 12pm - 1pm EDT.
Webinar hosted by MCRA.
---------------------------------------------------------
MCRA, an IQVIA business, is the leading therapy focused global full-service medical device, diagnostics & biologics CRO & consulting advisory firm.
MCRA is the pioneer and leader in integrating its core service offerings to bring healthcare innovation to the market globally, from conception to commercialization.
Our team of industry leading talent, including former FDA reviewers, notified body decision makers, clinical subject matter experts, reimbursement veterans and payers, provides in-depth therapeutic knowledge and thorough market understanding to each project we take.
MCRA's Service Offerings:
- Full Service Clinical Research Organization
- Global Regulatory Support
- US Regulatory Support
- Reimbursement, Healthcare Economics & Market Access
- Quality Assurance & Quality Operations
- Healthcare Compliance
- Cybersecurity
- Due Diligence
- AI & Imaging Center
- Talent Solutions
Learn more about MCRA at www.mcra.com.
Переглядів: 98

Відео

LDT vs IVD: Adapting to the New FDA Regulations - MCRA Webinar
Переглядів 3222 місяці тому
The US FDA recently released its final rule on the regulation of Laboratory Developed Tests (LDTs). MCRA’s IVD experts have been proactively engaged in understanding and preparing for this significant regulatory development, including analyzing the quality and clinical implications. Join us as we delve into the timeline for enforcement, the key aspects of the ruling, and how your organization c...
Reimbursement Considerations in Product Commercialization - MCRA Webinar
Переглядів 3483 місяці тому
Market Access and Reimbursement are often overlooked when a product is being brought to market. Unfortunately, this can result in numerous issues and delays in the adoption process for a new technology. By taking early action, companies can avoid many problems which can limit their uptake in the market. In this webinar, MCRA experts Michael Anselmo, John Schmitt, Anne O'Brien and Nicole Fitzpat...
Transition from EFS to Pivotal for Implanted BCI Devices - MCRA Webinar
Переглядів 1275 місяців тому
Transition from EFS to Pivotal for Implanted BCI Devices: Patient, Regulatory, and Reimbursement Perspectives Webinar All implantable BCI systems are currently in the early feasibility stage. Historically, most of these studies were investigator sponsor studies that were academically based and fell within the category of Early Feasibility Studies (EFS). In the last few years, medical device man...
FDA Cybersecurity and Software Policy Updates: Navigating the New FDA Guidance Documents for MedTech
Переглядів 1,7 тис.Рік тому
In recent months, the US FDA has published several guidance documents related to SaMD, SiMD and connected medical devices that shift the regulatory landscape for both new and experienced medical device companies. This 90-minute webinar provides an overview of these landscape shifts and a panel discussion on the practical implications and applications with experienced regulatory, quality, cybers...
Reimbursement, Market Access Strategy, and the Importance of a Patient Access Program
Переглядів 2173 роки тому
A video highlighting a portion of a MCRA webinar. The speaker is Tonya Dowd, MPH, our VP of Reimbursement, Health Economics & Market Access. MCRA is the leading therapy-focused clinical research organization (CRO) and consulting firm specializing in global clinical and regulatory affairs, reimbursement and market access, quality assurance, compliance and cybersecurity support for the medical de...
MCRA Webinar Clip 2: MDR Requirements: What is Sufficient Clinical Evidence in Europe
Переглядів 1843 роки тому
A video highlighting a portion of the webinar on Navigation of MDR Expectations for Tomorrow Based on Notified Body Feedback Today.
MCRA Webinar Clip 2: Understanding the FDA Breakthrough Device Designation Pathway
Переглядів 1743 роки тому
A video highlighting a portion of the webinar on FDA Breakthrough Designation Regulatory and Reimbursement Trends: Market From the Former FDA Acting Director of Breakthrough.
MCRA Webinar Clip: Early US Reimbursement & Market Access: It's Not Optional
Переглядів 2473 роки тому
A video highlighting a portion of the webinar, 'Early US Reimbursement & Market Access: It’s Not Optional', as part of a webinar series. Tonya Dowd, MPH, our VP of Reimbursement, Health Economics & Market Access speaks extensively about topics such as learning and understanding the fundamentals of Reimbursement and Market Access from an early planning standpoint, to how to review a best practic...
Using Patient Access Programs to support patient access to new and emerging technologies
Переглядів 1763 роки тому
MCRA, LLC partnered with LSX to present a webinar on 'Using Patient Access Programs to support patient access to new and emerging technologies'. Tonya Dowd, MPH, our VP of Reimbursement, Health Economics & Market Access, and Amanda Rhoades, Director of Reimbursement, speak extensively about topics such as learning how Category 3 CPT codes for new technology have evolved, how to determine if a P...
FDA Breakthrough Device Program - Regulatory and Reimbursement Insights
Переглядів 1,3 тис.3 роки тому
MCRA, LLC partnered with LSX present a webinar on FDA Breakthrough Designation Regulatory and Reimbursement Trends: Market From the Former FDA Acting Director of Breakthrough.
Wound Care Innovation: The Call to Clinical Action
Переглядів 1933 роки тому
MCRA, LLC partnered with LSX to present a webinar on Wound Care Innovation: The Call to Clinical Action.
The Path to US Market for Digital Health Technologies
Переглядів 1403 роки тому
MCRA, LLC partnered with LSX to present a webinar on Digital Health US Market Pathways: Navigating an Evolving Regulatory Framework.
Medical Device Materials: The US and EU Biocompatibility Regulatory Landscape
Переглядів 1483 роки тому
MCRA, LLC partnered with LSX to present a webinar on Medical Device Materials: The US and EU Biocompatibility Regulatory Landscape.
LSX London 2021 Medtech Virtual Congress - Evidence Generation For Optimal Market Adoption
Переглядів 333 роки тому
MCRA, LLC partnered with LSX to present a webinar on the Evidence Generation for Optimal Market Adoption.
The Future of Medical Devices: How COVID-19 and the Rise of Digital Health has changed the landscape
Переглядів 1343 роки тому
The Future of Medical Devices: How COVID-19 and the Rise of Digital Health has changed the landscape
Early US Reimbursement & Market Access: It's Not Optional
Переглядів 2,7 тис.3 роки тому
Early US Reimbursement & Market Access: It's Not Optional
Navigating MDR expectations for tomorrow based on Notified Body feedback today
Переглядів 603 роки тому
Navigating MDR expectations for tomorrow based on Notified Body feedback today
Considerations for Orthopedic Implant Associated Antimicrobial Agents: Regulatory Science
Переглядів 4233 роки тому
Considerations for Orthopedic Implant Associated Antimicrobial Agents: Regulatory Science

КОМЕНТАРІ

  • @shakirmanzoorkhan6348
    @shakirmanzoorkhan6348 2 роки тому

    very informative video, can I have copy of presentation for learning purpose

  • @MDRAMIMTANVERRahman
    @MDRAMIMTANVERRahman 3 роки тому

    Informative presentation, Thanks Dr Mehdi and MCRA LLC. Regards- Ramim Anti-microbial peptide researcher